Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: Comparison with FDG PET

Journal of Nuclear Medicine

Volumn 40, Issue 4, 1999, Pages 566-573

  Tatsumi, Mitsuaki ^a   Yutani, Kenji ^a   Watanabe, Yoshiyuki ^a   Miyoshi, Shinichiro ^a   Tomiyama, Noriyuki ^a   Johkoh, Takeshi ^a   Kusuoka, Hideo ^a   Nakamura, Hironobu ^a   Nishimura, Tsunehiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Fluorodeoxyglucose; Gamma camera coincidence imaging; Lung cancer; PET

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTILLATION CAMERA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; FEASIBILITY STUDIES; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GAMMA CAMERAS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032908270     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology. 1991;178:705-713.
2. Sum P, Atkins HL, Bandoypadhyay D, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med. 1980;21:670-675.
3. 18F-2-deoxy-2-fluoro-D-glucose (FDG) uptake in human tumor xenografts: feasibility studies for cancer imaging with PET. Cancer. 1991;67:1544-1550.
4. Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer. 1987;60:2682-2689.
5. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med. 1990;31: 1927-1932.
6. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 1992; 184:441-444.
7. Patz EF Jr, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-Z18 fluorodeoxyglucose PET scanning. Radiology. 1993;188:487-490.
8. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest. 1993;104:997-1002.
9. Knight SB, Delbeke D, Stewart JR, Sandler MP. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest. 1996;109:982-988.
10. Wahl RL, Quint LE, Greenough RL, Meyer CR. White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology. 1994;191:371-377.
11. Chin R Jr, Ward R, Keyes JW, et al. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med. 1995;152:2090-2096.
12. 18FDG in patients with bronchogenic carcinoma. Chest. 1995;108: 1617-1621.
13. Sazon DA, Santiago SM, Soo Hoo GW, et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 1996;153:417-421.
14. Sasaki M, Ichiya Y, Kuwabara Y, et al. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography. Eur J Nucl Med. 1996;23:741-747.
15. 18F]FDG positron emission tomography (PET). Thorax. 1997;52:438-441.
16. Steinert HC, Hauser M, Allemann R, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.Radiology. 1997;202:441-446.
17. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology. 1993;189:847-850.
18. Lowe VJ, Hoffman JM, Delong DM, Patz EF Jr. Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med. 1994;35:1771-1776.
19. Slosman DO, Spiliopoulos A, Couson F, et al. Satellite PET and lung cancer: a prospective study in surgical patients. Nucl Med Commun. 1993;14:955-961.
20. Van Lingen A, Huijgens PC, Visser FC, et al. Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma camera. Eur J Nucl Med. 1992;19:315-321.
21. Drane WE, Abbott FD, Nicole MW, Mastin ST, Kuperus JH Technology for FDG SPECT with 3 relatively inexpensive gamma camera. Radiology. 1994;191:461-465.
22. Martin WH, Delbeke D, Patton JA, Sandler MP. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose. Radiology. 1996;198:225-231.
23. Holle LH, Trampert L, Lung Kurt S, et al. Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT. J Nucl Med. 1996;37:615-622.
24. Matsuno S, Tanabe M, Kawasaki Y, et al. Effectiveness of planar image and single photon emission tomography of thallium-201 compared with gallium-67 in patients with primary lung cancer. Eur J Nucl Med. 1992;19:86-95.
25. Abdel Dayem HM, Scott A, Macapinlac H, Larson S. Tracer imaging in lung cancer. Eur J Nucl Med. 1994;21:57-81.
26. Hassan IM, Sahweil A, Constantinides C, et al. Uptake and kinetics of technetium-99m-hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med. 1989;14:333-340.
27. Actolun C, Bayhan H, Kir M. Clinical experience with technetium-99m-MIBI imaging in patients with malignant tumors: preliminary results and comparison with thallium-201. Clin Nucl Med. 1992;17:171-176.
28. Kao CH, Wang SJ, Lin WY, Hsu CY, Liao SQ, Yeh SH. Differentiation of single solid lesions in the lungs by means of single photon emission tomography with technetium-99m-methoxyisobutylisonitrile. Eur J Nucl Med. 1993;20:249-254.
29. Nishivama Y, Kawasaki Y, Yamamoto Y, et al. Technetium-99m-MIBI and thallium-201 scintigraphy of primary lung cancer. J Nucl Med 1997;38:1358-1361.
30. Higashi K, Nishikawa T, Seki H, et al. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer. J Nucl Med. 1998;39:9-15.
31. Coleman RE, Laymon CE, Turkington TG. Positron imaging of pulmonary nodules: phantom study [abstract]. J Nucl Med. 1998; 39(suppl):108p.
32. Budinger TF, Brennan KM, Moses WW, Derenzo SE. Advances in positron tomography for oncology. Nucl Med Biol. 1996; 23:659-667.
33. Cherry SR, Dahlbom M, Hoffman EJ. 3D PET using a conventional multislice tomograph without septa. J Cumput Assist Tomogr. 1991;15:655-668.
34. 18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung. Eur J Nucl Med 1996;23:517-523.
35. Hamberg LM, Hunter GJ, Alpen NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplitication? J Nucl Med 1994;35:1308-1312.